Navigation Links
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial
Date:9/29/2011

Scientific.  "This novel technology leverages Boston Scientific's capabilities in cardiac rhythm management device therapy, lead technologies and neuromodulation.  This treatment capability is one of our Priority Growth Initiatives, and illustrates our strategy to offer new therapies in high-potential markets that are designed to improve the quality of life for patients."

Congestive heart failure affects nearly 23 million people worldwide, with approximately 2 million new patients diagnosed annually.  Despite substantial advances over the past two decades in pharmacological and device therapy, heart failure remains one of the leading causes of morbidity and mortality in the U.S. and most European countries.

About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding new product launches and launch cadence, regulatory approvals, clinical trials, vagal nerve stimulation, product performance and competitive offerings.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertain
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... -- Research and Markets  has announced the addition of ... their offering. Global Market Report of Pralmorelin ... and regionally ( Europe , Asia ... Latin America etc.). It captures Pralmorelin market trends, ... on three primary areas; manufacture methods & technology development, market ...
(Date:8/20/2014)... Ariz. , Aug. 20, 2014   ... the  Roche  Group, today announced that its VENTANA ... CE marked in the European Union for routine ... The system, consisting of VENTANA Virtuoso software coupled ... VENTANA iScan HT slide scanner, provides automated digital ...
(Date:8/20/2014)... PHOENIX , Aug. 20, 2014 /PRNewswire-USNewswire/ ... next-generation sequencing and proteomic diagnostics and biomarker driven ... collaboration with TESARO, Inc.  Paradigm will use its ... from clinical trials to better predict which patients ... may lead to more successful clinical trial outcomes ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
(Date:8/21/2014)... According to new market research ... Food & Beverage, Personal care & Pharmaceutical) & ... Electronics, Textile) & Geography - Global Trends & ... polylactic acid markets and segments with analyses and ... on their sub-segments, in terms of value and ...
(Date:8/21/2014)... San Luis Obispo, CA (PRWEB) August 21, 2014 ... July/August edition of Current Pedorthics, a bi-monthly publication of the ... the field of pedorthics. , Bunion Bootie ... as an alternative solution for bunion sufferers and their pain. ... be worn in nearly any shoe to eliminate the friction ...
(Date:8/21/2014)... WA (PRWEB) August 21, 2014 While ... Grant, found it hard to stay focused on his ... and mosquitoes. The constant whine, slapping and continual need ... researching innovative methods to stay protected from insects while ... successful career in the Financial Services/Investment Banking Industry, decided ...
(Date:8/21/2014)... 2014 Atlantic Information Services, Inc. (AIS) ... News and The AIS Report on Blue Cross & ... Blue Shield Association or its member companies) — is ... in AIS’s Management Insight Series. Bundled Payment Models: ... two insurers — Horizon Healthcare Services, Inc. and Arkansas ...
(Date:8/21/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on Dianeal Low Calcium ... announced on August 15, that two lots of Dianeal ... 5000mL (Ambu-Flex II), by Baxter International Inc., are ... , The reason for the recall is the ...
Breaking Medicine News(10 mins):Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 2Health News:Lactic Acid Market Worth $3,577.5 Million & Polylactic Acid Market Worth $4,840.1 Million by 2019 – New Report 3Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 2Health News:Recently Featured in Current Pedorthics: Bunion Bootie, the Very Popular Bunion Treatment Splint 3Health News:Financial VP Fights Pesky Bugs with Launch of Biteback Sports Insect Shield® Golf Apparel 2Health News:New AIS Report Highlights Two Case Studies of Bundled Payment Models 2Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
... humans are genetically more suited to being vegetarians than meat-eaters ... conference by more then 300 leading scientists from New Zealand ... finding a cure for cancer is also under discussion at ... Convener of the conference says the finding that a human ...
... drawer, the time-honored lessons of helping organize one’s clothes learned ... to encode such categories as socks, shirts, or any other ... research from Harvard Medical School (HMS) investigators has identified an ... report in the advanced online Nature that they have identified ...
... Palmerston North high school, 500 will undergo testing this week ... students will be tested in the coming weeks. ... and laboratory tests have now confirmed the boy has tuberculosis. ... and parents revealed exposure to the infecting bacteria. The remaining ...
... skin lightening products are available over the counter but the ... over the counter skin lighteners that contain hydroquinone because studies ... causing. ,Dermatologist, Dr. Mathew Avram, of Massachusetts General Hospital ... here. I think they haven't seen the data to show ...
... that studies that were being conducted towards pest control ... ,Researchers from the University of California, have stated ... been identified by researchers who were initially looking for ... for people suffering from arthritis and other inflammatory diseases. ...
... present in almost every medicine cabinet, may help in easing ... Clinic.// ,Aspirin is known to help in the ... of cancer along with headaches. The researchers say that now ... to have been connected with enlarged prostates. ,It ...
Cached Medicine News:Health News:Brain's Filing System Uncovered 2Health News:Brain's Filing System Uncovered 3Health News:Pest Control research Leads to Pain Control Discovery 2Health News:Pest Control research Leads to Pain Control Discovery 3
... The BiPAP Pro with Bi-Flex bi-level system, ... that the BiPAP Pro takes to change ... Digital Auto-Trak Sensitivity™ which automatically triggers the ... pressures based on the patients breathing rhythm. ...
... Electrophoresis System (PGGE) is designed to ... density lipoproteins (LDL) and high density ... using nondenaturing pore gradient gel electrophoresis. ... short DNA sequencing runs. Temperature control ...
This control is intended for monitoring cell counts in patient cerebrospinal fluid samples, performed manually using a hemocytometer. Spinalscopics is fortified to target levels with purified chemica...
... Suitable for use with Leica ... bilirubinometers (pediatric) and all automated ... including Aeroset, AU Series, Cobas, ... These controls contain purified bilirubin ...
Medicine Products: